What have we learned from six years of GWAS in autoimmune diseases, and what is next?

Current Opinion in Immunology

Volumn 24, Issue 5, 2012, Pages 571-575

  Hu, Xinli ^a,b,c   Daly, Mark ^c,d  

^a HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNITY; FOLLOW UP; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE SYSTEM; IMMUNOPHENOTYPING; INFLAMMATION; MOLECULAR MECHANICS; PATHOGENESIS; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

AUTOIMMUNE DISEASES; FOLLOW-UP STUDIES; FORECASTING; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IMMUNOPHENOTYPING; PROTEIN INTERACTION MAPPING; RISK FACTORS;

EID: 84867745132     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.09.001     Document Type: Review

References (43)

1. Hindorff LA, MacArthur J, Wise A, Junkins HA, Hall PN, Klemm AK, Manolio TA: A Catalog of Published Genome-Wide Association Studies. Available at: Accessed [22.08.12]. http://www.genome.gov/gwastudies.
2. Anderson C.A., Soranzo N., Zeggini E., Barrett J.C. Synthetic associations are unlikely to account for many common disease genome-wide association signals. PLoS Biol 2011, 9:e1000580.
3. Gorlatova N., Chao K., Pal L.R., Araj R.H., Galkin A., Turko I., Moult J., Herzberg O. Protein characterization of a candidate mechanism SNP for Crohn's disease: the macrophage stimulating protein R689C substitution. PLoS ONE 2011, 6:e27269.
4. Guerini F.R., Cagliani R., Forni D., Agliardi C., Caputo D., Cassinotti A., Galimberti D., Fenoglio C., Biasin M., Asselta R., et al. A functional variant in ERAP1 predisposes to multiple sclerosis. PLoS ONE 2012, 7:e29931.
5. Pidasheva S., Trifari S., Phillips A., Hackney J.A., Ma Y., Smith A., Sohn S.J., Spits H., Little R.D., Behrens T.W., et al. Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS ONE 2011, 6:e25038.
6. Liu Z., Lee J., Krummey S., Lu W., Cai H., Lenardo M.J. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat Immunol 2011, 12:1063-1070.
7. Okada Y., Yamazaki K., Umeno J., Takahashi A., Kumasaka N., Ashikawa K., Aoi T., Takazoe M., Matsui T., Hirano A., et al. HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease. Gastroenterology 2011, 141:864-871. e861-865.
8. Raychaudhuri S., Sandor C., Stahl E.A., Freudenberg J., Lee H.S., Jia X., Alfredsson L., Padyukov L., Klareskog L., Worthington J. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012, 44:291-296.
9. Rossi F., Bellini G., Tolone C., Luongo L., Mancusi S., Papparella A., Sturgeon C., Fasano A., Nobili B., Perrone L., et al. The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention. Pharmacol Res 2012, 66:88-94.
10. Tejasvi T., Stuart P.E., Chandran V., Voorhees J.J., Gladman D.D., Rahman P., Elder J.T., Nair R.P. TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. J Invest Dermatol 2012, 132:593-600.
11. Wang S., Adrianto I., Wiley G.B., Lessard C.J., Kelly J.A., Adler A.J., Glenn S.B., Williams A.H., Ziegler J.T., Comeau M.E., et al. A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus. Genes Immun 2012, 13:380-387.
12. Wiede F., Shields B.J., Chew S.H., Kyparissoudis K., van Vliet C., Galic S., Tremblay M.L., Russell S.M., Godfrey D.I., Tiganis T. T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. J Clin Invest 2011, 121:4758-4774.
13. Zhou J., Wu R., High A.A., Slaughter C.A., Finkelstein D., Rehg J.E., Redecke V., Hacker H. A20-binding inhibitor of NF-kappaB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein beta activation and protects from inflammatory disease. Proc Natl Acad Sci USA 2011, 108:E998-E1006.
14. Stastny P. HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1978, 21:S139-S143.
15. Bakir-Gungor B., Sezerman O.U. A new methodology to associate SNPs with human diseases according to their pathway related context. PLoS ONE 2011, 6:e26277.
16. Chen M., Cho J., Zhao H. Incorporating biological pathways via a Markov random field model in genome-wide association studies. PLoS Genet 2011, 7:e1001353.
17. Cleynen I., Juni P., Bekkering G.E., Nuesch E., Mendes C.T., Schmied S., Wyder S., Kellen E., Villiger P.M., Rutgeerts P., et al. Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review. PLoS ONE 2011, 6:e24106.
18. Nakaoka H., Cui T., Tajima A., Oka A., Mitsunaga S., Kashiwase K., Homma Y., Sato S., Suzuki Y., Inoko H., et al. A systems genetics approach provides a bridge from discovered genetic variants to biological pathways in rheumatoid arthritis. PLoS ONE 2011, 6:e25389.
19. Hu X., Kim H., Stahl E., Plenge R., Daly M., Raychaudhuri S. Integrating autoimmune risk loci with gene-expression data identifies specific pathogenic immune cell subsets. Am J Hum Genet 2011, 89:496-506.
20. Lee I., Blom U.M., Wang P.I., Shim J.E., Marcotte E.M. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Res 2011, 21:1109-1121.
21. Bergholdt R., Brorsson C., Palleja A., Berchtold L.A., Floyel T., Bang-Berthelsen C.H., Frederiksen K.S., Jensen L.J., Storling J., Pociot F. Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 2012, 61:954-962.
22. Akula N., Baranova A., Seto D., Solka J., Nalls M.A., Singleton A., Ferrucci L., Tanaka T., Bandinelli S., Cho Y.S., et al. A network-based approach to prioritize results from genome-wide association studies. PLoS ONE 2011, 6:e24220.
23. Rossin E.J., Lage K., Raychaudhuri S., Xavier R.J., Tatar D., Benita Y., Cotsapas C., Daly M.J. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet 2011, 7:e1001273.
24. Fehrmann R.S., Jansen R.C., Veldink J.H., Westra H.J., Arends D., Bonder M.J., Fu J., Deelen P., Groen H.J., Smolonska A., et al. Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet 2011, 7:e1002197.
25. Corona E., Dudley J.T., Butte A.J. Extreme evolutionary disparities seen in positive selection across seven complex diseases. PLoS ONE 2010, 5:e12236.
26. Eyre S., Hinks A., Bowes J., Flynn E., Martin P., Wilson A.G., Morgan A.W., Emery P., Steer S., Hocking L.J., et al. Overlapping genetic susceptibility variants between three autoimmune disorders: rheumatoid arthritis, type 1 diabetes and coeliac disease. Arthritis Res Ther 2010, 12:R175.
27. Suzuki A., Kochi Y., Okada Y., Yamamoto K. Insight from genome-wide association studies in rheumatoid arthritis and multiple sclerosis. FEBS Lett 2011, 585:3627-3632.
28. Ramos P.S., Criswell L.A., Moser K.L., Comeau M.E., Williams A.H., Pajewski N.M., Chung S.A., Graham R.R., Zidovetzki R., Kelly J.A., et al. A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet 2011, 7:e1002406.
29. Menon R., Farina C. Shared molecular and functional frameworks among five complex human disorders: a comparative study on interactomes linked to susceptibility genes. PLoS ONE 2011, 6:e18660.
30. Lewis S.N., Nsoesie E., Weeks C., Qiao D., Zhang L. Prediction of disease and phenotype associations from genome-wide association studies. PLoS ONE 2011, 6:e27175.
31. Cotsapas C., Voight B.F., Rossin E., Lage K., Neale B.M., Wallace C., Abecasis G.R., Barrett J.C., Behrens T., Cho J., et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet 2011, 7:e1002254.
32. So H.C., Li M., Sham P.C. Uncovering the total heritability explained by all true susceptibility variants in a genome-wide association study. Genet Epidemiol 2011, 35:447-456.
33. Visscher P.M., Brown M.A., McCarthy M.I., Yang J. Five years of GWAS discovery. Am J Hum Genet 2012, 90:7-24.
34. Gibson G. Hints of hidden heritability in GWAS. Nat Genet 2010, 42:558-560.
35. Lee S.H., Wray N.R., Goddard M.E., Visscher P.M. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet 2011, 88:294-305.
36. Stahl E.A., Wegmann D., Trynka G., Gutierrez-Achury J., Do R., Voight B.F., Kraft P., Chen R., Kallberg H.J., Kurreeman F.A., et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet 2012, 44:483-489.
37. Park J.H., Wacholder S., Gail M.H., Peters U., Jacobs K.B., Chanock S.J., Chatterjee N. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 2010, 42:570-575.
38. Feng T., Zhu X. Genome-wide searching of rare genetic variants in WTCCC data. Hum Genet 2010, 128:269-280.
39. Lehne B., Lewis C.M., Schlitt T. Exome localization of complex disease association signals. BMC Genomics 2011, 12:92.
40. Rivas M.A., Beaudoin M., Gardet A., Stevens C., Sharma Y., Zhang C.K., Boucher G., Ripke S., Ellinghaus D., Burtt N., et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011, 43:1066-1073.
41. Nejentsev S., Walker N., Riches D., Egholm M., Todd J.A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009, 324:387-389.
42. Trynka G., Hunt K.A., Bockett N.A., Romanos J., Mistry V., Szperl A., Bakker S.F., Bardella M.T., Bhaw-Rosun L., Castillejo G., et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011, 43:1193-1201.
43. Blumberg R.S., Dittel B., Hafler D., von Herrath M., Nestle F.O. Unraveling the autoimmune translational research process layer by layer. Nat Med 2012, 18:35-41.